MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.24 USD | -1.72% |
|
-3.42% | -3.26% |
| Jan. 21 | Morgan Stanley Adjusts Merck Price Target to $113 From $123, Maintains Equal Weight Rating | MT |
| Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MERCK & CO., INC. | Other Pharmaceuticals | -1.72% | -3.42% | -3.26% | -19.05% | +6.97% | 243B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MRK Stock
- Charts Merck & Co., Inc.
- Comparison Chart